• 1
    Caramori, G. and Adcock, I., Pharmacology of airway inflammation in asthma and COPD. Pulm. Pharmacol. Ther. 2003. 16: 247277.
  • 2
    Horner, A. A., Toll-like receptor ligands and atopy: a coin with at least two sides. J. Allergy Clin. Immunol. 2006. 117: 11331140.
  • 3
    Kawai, T. and Akira, S., TLR signaling. Cell Death Differ. 2006. 13: 816825.
  • 4
    Sasai, M., Matsumoto, M. and Seya, T., The kinase complex responsible for IRF-3-mediated IFN-beta production in myeloid dendritic cells (mDC). J. Biol. Chem. 2006. 139: 171175.
  • 5
    Bedoret, D., Wallemacq, H., Marichal, T., Desmet, C., Quesada Calvo, F., Henry, E., Closset, R. et al., Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J. Clin. Invest. 2009. 119: 37233738.
  • 6
    Liu, A. H., Innate microbial sensors and their relevance to allergy. J. Allergy Clin. Immunol. 2008. 122: 2008846–2008858; quiz 858860.
  • 7
    Horner, A. A., Regulation of aeroallergen immunity by the innate immune system: laboratory evidence for a new paradigm. J. Innate Immun. 2010. 2: 107113.
  • 8
    D'Adamio, F., Zollo, O., Moraca, R., Ayroldi, E., Bruscoli, S., Bartoli, A., Cannarile, L. et al., A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 1997. 7: 803812.
  • 9
    Ayroldi, E., Migliorati, G., Bruscoli, S., Marchetti, C., Zollo, O., Cannarile, L. and Riccardi, C., Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood 2001. 98: 743753.
  • 10
    Eddleston, J., Herschbach, J., Wagelie-Steffen, A. L., Christiansen, S. C. and Zuraw, B. L., The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J. Allergy Clin. Immunol. 2007. 119: 115122.
  • 11
    Godot, V., Garcia, G., Capel, F., Arock, M., Durand-Gasselin, I., Asselin-Labat, M. L., Emilie, D. and Humbert, M., Dexamethasone and IL-10 stimulate glucocorticoid-induced leucine zipper synthesis by human mast cells. Allergy 2006. 61: 886890.
  • 12
    Mittelstadt, P. R. and Ashwell, J. D., Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J. Biol. Chem. 2001. 276: 2960329610.
  • 13
    Gomez, M. S., Raju, V., Viswanathan, A., Painter, R. G., Bonvillain, R., Byrne, P., Nguyen, D. H. et al., Ethanol upregulates glucocorticoid-induced leucine zipper expression and modulates cellular inflammatory responses in lung epithelial cells. J. Immunol. 2010. 184: 57155722.
  • 14
    Berrebi, D., Bruscoli, S., Cohen, N., Foussat, A., Migliorati, G., Bouchet-Delbos, L., Maillot, M. C. et al., Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 2003. 101: 729738.
  • 15
    Di Marco, B., Massetti, M., Bruscoli, S., Macchiarulo, A., Di, V. R., Velardi, E., Donato, V. et al., Glucocorticoid-induced leucine zipper (GILZ)/NF-kappaB interaction: role of GILZ homo-dimerization and C-terminal domain. Nucleic Acids Res. 2007. 35: 517528.
  • 16
    Beaulieu, E. and Morand, E. F., Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis. Nat. Rev. Rheumatol. 2011. 7: 340348.
  • 17
    Zang, X. H., Lu, X., Long, X. B., You, X. J., Gao, Q. X., Cui, Y. H. and Liu, Z., Chronic rhinosinusitis with and without nasal polyps is associated with decreased expression of glucocorticoid-induced leucine zipper. Clin. Exp. Allergy 2009. 39: 647654.
  • 18
    Cannarile, L., Zollo, O., D'Adamio, F., Ayroldi, E., Marchetti, C., Tabilio, A., Bruscoli, S. and Riccardi, C., Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene. Cell Death Differ. 2001. 8: 201203.
  • 19
    Hoppstädter, J., Diesel, B., Zarbock, R., Breinig, T., Monz, D., Koch, M., Meyerhans, A., et al., Differential cell reaction upon Toll-like receptor 4 and 9 activation in human alveolar and lung interstitial macrophages. Respir. Res. 2010. 11: 124138.
  • 20
    Ladetzki-Baehs, K., Keller, M., Kiemer, A. K., Koch, E., Zahler, S., Wendel, A. and Vollmar, A. M., Atrial natriuretic peptide, a regulator of nuclear factor-kappaB activation in vivo. Endocrinology 2007. 148: 332336.
  • 21
    Barral, P. M., Sarkar, D., Su, Z. Z., Barber, G. N., DeSalle, R., Racaniello, V. R. and Fisher, P. B., Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity. Pharmacol. Ther. 2009. 124: 219234.
  • 22
    Eberhardt, W., Doller, A., Akool, E. and Pfeilschifter, J., Modulation of mRNA stability as a novel therapeutic approach. Pharmacol. Ther. 2007. 114: 5673.
  • 23
    Carballo, E., Lai, W. S. and Blackshear, P. J., Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 1998. 281: 10011005.
  • 24
    Stoecklin, G., Tenenbaum, S. A., Mayo, T., Chittur, S. V., George, A. D., Baroni, T. E., Blackshear, P. J. and Anderson, P., Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J. Biol. Chem. 2008. 283: 1168911699.
  • 25
    Sabroe, I., Parker, L. C., Dockrell, D. H.,. Davies, D. E., Dower, S. K. and Whyte, M. K., Targeting the networks that underpin contiguous immunity in asthma and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007. 175: 306311.
  • 26
    O'Donnell, R., Breen, D., Wilson, S. and Djukanovic, R., Inflammatory cells in the airways in COPD. Thorax 2006. 61: 448454.
  • 27
    Gordon, S., The macrophage: past, present and future. Eur. J. Immunol. 2007. 37(S1): 917.
  • 28
    Ayroldi, E. and Riccardi, C., Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J. 2009. 23: 36493658.
  • 29
    Soundararajan, R., Wang, J., Melters, D. and Pearce, D., Differential activities of glucocorticoid-induced leucine zipper protein isoforms. J Biol. Chem. 2007. 282: 3630336313.
  • 30
    Bruscoli, S., Donato, V., Velardi, E., Di Sante, M., Migliorati, G., Donato, R. and Riccardi, C., Glucocorticoid-induced leucine zipper (GILZ) and long GILZ inhibit myogenic differentiation and mediate anti-myogenic effects of glucocorticoids. J. Biol. Chem. 2010. 285: 1038510396.
  • 31
    Opitz, B., van Laak, V., Eitel, J. and Suttorp, N., Innate immune recognition in infectious and noninfectious diseases of the lung. Am. J. Respir. Crit. Care Med. 2010. 181: 12941309.
  • 32
    Cai, S., Batra, S., Shen, L., Wakamatsu, N. and Jeyaseelan, S., Both TRIF- and MyD88-dependent signaling contribute to host defense against pulmonary klebsiella infection. J. Immunol. 2009. 183: 66296638.
  • 33
    Hawn, T. R., Smith, K. D., Aderem, A. and Skerrett, S. J., Myeloid differentiation primary response gene (88)- and toll-like receptor 2-deficient mice are susceptible to infection with aerosolized Legionella pneumophila. J. Infect. Dis. 2006. 193: 16931702.
  • 34
    Wieland, C. W., Florquin, S., Maris, N. A., Hoebe, K., Beutler, B., Takeda, K., Akira, S. and van der Poll, T., The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable Haemophilus influenzae from the mouse lung. J. Immunol. 2005. 175: 60426049.
  • 35
    Albiger, B., Sandgren, A., Katsuragi, H., Meyer-Hoffert, U., Beiter, K., Wartha, F., Hornef, M., et al., Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice. Cell. Microbiol. 2005. 7: 16031615.
  • 36
    Wilusz, C. J. and Wilusz, J., Bringing the role of mRNA decay in the control of gene expression into focus. Trends Genet. 2004. 20: 491497.
  • 37
    Lasa, M., Mahtani, K. R., Finch, A., Brewer, G., Saklatvala, J. and Clark, A. R., Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol. Cell. Biol. 2000. 20: 42654274.
  • 38
    Bakheet, T., Frevel, M., Williams, B. R., Greer, W. and Khabar, K. S., ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res. 2001. 29: 246254.
  • 39
    Werno, C., Schmid, T., Schnitzer, S. E., Peters, K., Milke, L. and Brüne, B., A combination of hypoxia and lipopolysaccharide activates tristetraprolin to destabilize proinflammatory mRNAs such as tumor necrosis factor-alpha. Amer. J. Pathol. 2010. 177: 11041112.
  • 40
    Chen, C. Y. and Shyu, A. B., AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 1995. 20: 465470.
  • 41
    Barreau, C., Paillard, L. and Osborne, H. B., AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 2005. 33: 71387150.
  • 42
    Hollams, E. M., Giles, K. M., Thomson, A. M. and Leedman, P. J., mRNA stability and the control of gene expression: implications for human disease. Neurochem. Res. 2002. 27: 957980.
  • 43
    Lai, W. S., Carballo, E., Strum, J. R., Kennington, E. A., Phillips, R. S. and Blackshear, P. J., Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol. Cell. Biol. 1999. 19: 43114323.
  • 44
    Brooks, S. A., Connolly, J. E. and Rigby, W. F., The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway. J. Immunol. 2004. 72: 72637271.
  • 45
    Carrick, D. M. and Blackshear, P. J., Comparative expression of tristetraprolin (TTP) family member transcripts in normal human tissues and cancer cell lines. Arch. Biochem. Biophys. 2007. 462: 278285.
  • 46
    Kiemer, A. K., Senaratne, R. H., Hoppstädter, J., Diesel, B., Riley, L. W., Tabeta, K., Bauer, S. et al., Attenuated activation of macrophage TLR9 by DNA from virulent mycobacteria. J. Innate Immun. 2009. 1: 2945.
  • 47
    Diesel, B., Ripoche, N., Risch, R. T., Tierling, S., Walter, J. and Kiemer, A. K., Inflammation-induced up-regulation of TLR2 expression in human endothelial cells is independent of differential methylation in the TLR2 promoter CpG island. Innate Immun. 2012. 18: 112123.
  • 48
    Tybl, E., Shi, F., Kessler, S. M., Tierling, S., Walter, J., Bohle, R. M., Wieland, S. et al., Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype. J. Hepatol. 2011. 54: 9941001.
  • 49
    Kiemer, A. K. and Vollmar, A., Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide. J. Biol. Chem. 1998. 273: 1344413451.
  • 50
    Dünschede, F., Tybl, E., Kiemer, A. K., Dutkowski, P., Erbes, K., Kircher, A., Gockel, I. et al., Bcl-2 upregulation after 3-nitropropionic acid preconditioning in warm rat liver ischemia. Shock 2008. 30: 699704.
  • 51
    Fechir, M., Linker, K., Pautz, A., Hubrich, T., Förstermann, U., Rodriguez-Pascual, F. and Kleinert, H., Tristetraprolin regulates the expression of the human inducible nitric-oxide synthase gene. Mol. Pharmacol. 2005. 67: 21482161.